Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
Status:
Completed
Trial end date:
2016-04-29
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo controlled, multicenter study in male and female
participants who are seeking treatment for opioid use disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Indivior Inc.
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination